Interaction of Adenosine, Modified Using Carborane Clusters, with Ovarian Cancer Cells: A New Anticancer Approach against Chemoresistance
Platinum compounds remain the first-line drugs for the treatment of most lethal gynecological malignancies and ovarian cancers. Acquired platinum resistance remains a major challenge in gynecological oncology. Considering the unique physicochemical properties of the metallacarboranes modifier and th...
Main Authors: | Katarzyna Bednarska-Szczepaniak, Ewelina Przelazły, Katarzyna Dominika Kania, Marzena Szwed, Miroslava Litecká, Bohumír Grűner, Zbigniew J. Leśnikowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3855 |
Similar Items
-
Cisplatin for cancer therapy and overcoming chemoresistance
by: Ranmali Ranasinghe, et al.
Published: (2022-09-01) -
The Expression of ZNF268 and Its Role in The Cisplatin-based Chemoresistance of Breast Cancer
by: Weilu Wu, et al.
Published: (2023-08-01) -
Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
by: Linjiao Chen, et al.
Published: (2022-08-01) -
MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway
by: Yang Li, et al.
Published: (2022-02-01) -
Comparative Study of Carborane- and Phenyl-Modified Adenosine Derivatives as Ligands for the A2A and A3 Adenosine Receptors Based on a Rigid in Silico Docking and Radioligand Replacement Assay
by: Marian Vincenzi, et al.
Published: (2018-07-01)